# Mayne Pharma Group Ltd: Form D filings

Mayne Pharma Group Ltd, a pharmaceuticals company in Melbourne, Victoria, Australia, filed 2 Form D notices with the SEC between 2012 and 2013. The latest, on February 8, 2013, reports $141,770 sold of a $346,500 offering to 14 investors.

Find out what Mayne Pharma Group Ltd does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Mayne%20Pharma%20Group%20Ltd%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Mayne%20Pharma%20Group%20Ltd&page=%2Fdata%2Fform-d%2Fcompany%2Fmayne-pharma-group-ltd-1560183)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Mayne%20Pharma%20Group%20Ltd%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Mayne%20Pharma%20Group%20Ltd&page=%2Fdata%2Fform-d%2Fcompany%2Fmayne-pharma-group-ltd-1560183)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: Level 14, 474 Flinders Street, Melbourne, Victoria, Australia, 3000
- Phone: 61 3 9614 7022
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Australia
- Revenue range: $25,000,001 - $100,000,000
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1560183

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Feb 8, 2013 | New notice | $346,500 | $141,770 | $204,730 | 14 | Jan 24, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1560183/000156018313000001/0001560183-13-000001-index.htm) |
| Oct 12, 2012 | New notice | $2,705,000 | $2,705,000 | $0 | 14 | Sep 27, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1560183/000156018312000001/0001560183-12-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Christelle Simpson | Executive Officer |  |
| Leigh Willis | Executive Officer |  |
| Stefan Cross | Executive Officer |  |
| Roger Corbett | Director |  |
| Ian Scholes | Director |  |
| Peter Truelove | Executive Officer |  |
| Stefan Lukas | Executive Officer |  |
| Richard Moldin | Executive Officer |  |
| Ron Best | Director |  |
| Brenton Walter | Executive Officer |  |
| Mark Cansdale | Executive Officer |  |
| Stuart Mudge | Executive Officer |  |
| Scott Richards | Executive Officer, Director |  |
| Bruce Mathieson | Director |  |
| Phil Hodges | Executive Officer, Director |  |
| Vince Caretti | Executive Officer |  |

[Every Form D from the week of Feb 4, 2013](https://specstream.ai/data/form-d/week/2013-02-04) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Mayne Pharma Group Ltd reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).